
Apr 03, 2026
2 minutes
New Oncology Prior Authorization Requirements Announced for 2026
Effective October 1, 2026, new prior authorization requirements will be implemented for specific oncology-related procedure and medication codes across multiple health plans. The update applies broadly to commercial, Medicare, Medicaid, and individual exchange plans, aligning with recent procedure code changes issued by the Centers for Medicare & Medicaid Services (CMS) and the American Medical Association (AMA).
Key Changes
Prior authorization will now be required for the following HCPCS codes when used in outpatient settings for cancer treatment:
- G0562: Therapeutic radiology simulation-aided field setting; complex, including PET and CT imaging data acquisition for radiopharmaceutical-directed radiation therapy planning.
- G0563: Stereotactic body radiation therapy (SBRT), including image guidance and real-time positron emission-based delivery adjustments, with a maximum of five fractions per treatment course.
- J2860: Injection, siltuximab, 10 mg.
Plans and Coverage Impacted
The updated prior authorization requirements will affect a wide range of plans under UnitedHealthcare, including:
- UnitedHealthcare Commercial Plans (nationwide)
- UnitedHealthcare Medicare Advantage Plans (all states)
- UnitedHealthcare Community Plan (Medicaid)
- UnitedHealthcare Individual & Family ACA Marketplace Plans
UnitedHealthcare Community Plan
- Arizona
- Colorado
- Florida
- Hawaii
- Kansas
- Kentucky
- Louisiana
- Maryland
- Mississippi
- Nebraska
- New Jersey
- New Mexico
- New York
- Ohio
- Pennsylvania
- Rhode Island
- Tennessee
- Texas
- Virginia
- Washington
- Wisconsin
UnitedHealthcare Individual Exchange plans
- Alabama
- Arizona
- Colorado
- Louisiana
- Maryland
- Michigan
- Missouri
- Mississippi
- North Carolina
- Nebraska
- Florida
- Georgia
- Indiana
- New Jersey
- New Mexico
- New York
- Ohio
- Oklahoma
- South Carolina
- Tennessee
- Illinois
- Iowa
- Kansas
- Texas
- Virginia
- Washington
- Wisconsin
- Wyoming
Support and Resources
For additional guidance or clarification, providers can:
- Email: unitedoncology@uhc.com
- Call: 888-397-8129
- Visit the Oncology Prior Authorization and Notification page via UnitedHealthcare’s official resources























